(HealthDay)—For patients with recurrent vasovagal syncope and no serious comorbid conditions, midodrine can reduce the recurrence of syncope, according to
Midodrine cuts recurrent syncope in young, healthy patients
Home »
Rutgers reports first instance of COVID-19 triggering recurrent Guillain-Barré Syndrome
Researchers at Rutgers Robert Wood Johnson Medical School have reported the first instance of COVID-19 triggering a recurrence of Guillain-Barré